Your browser doesn't support javascript.
loading
Unlocking the potential: phenylboronic acid as a nuclear-targeting boron agent for neutron capture therapy.
Chen, Jiejian; Li, Yonghao; Gan, Xiaoning; Weng, Chengyin; Fang, Xisheng; Liu, Guolong.
Affiliation
  • Chen J; Department of Medical Oncology, Guangzhou First People's Hospital, School of Medicine, South China University of Technology, Guangzhou, 510180, Guangdong, China.
  • Li Y; Department of Medical Oncology, Guangzhou First People's Hospital, School of Medicine, South China University of Technology, Guangzhou, 510180, Guangdong, China.
  • Gan X; Department of Medical Oncology, Guangzhou First People's Hospital, School of Medicine, South China University of Technology, Guangzhou, 510180, Guangdong, China.
  • Weng C; Department of Medical Oncology, Guangzhou First People's Hospital, School of Medicine, South China University of Technology, Guangzhou, 510180, Guangdong, China.
  • Fang X; Department of Medical Oncology, Guangzhou First People's Hospital, School of Medicine, South China University of Technology, Guangzhou, 510180, Guangdong, China.
  • Liu G; Department of Medical Oncology, Guangzhou First People's Hospital, School of Medicine, South China University of Technology, Guangzhou, 510180, Guangdong, China. eyglliu@scut.edu.cn.
Med Oncol ; 41(5): 104, 2024 Apr 04.
Article in En | MEDLINE | ID: mdl-38573420
ABSTRACT
It has been proposed that boron neutron capture therapy (BNCT) holds promise as a treatment modality for melanoma. However, the effectiveness of boron agents in delivery remains a critical issue to be addressed for BNCT. To this end, phenylboronic acid, which exhibits good water solubility and low cytotoxicity similar to BPA, has been investigated as a potential nuclear-targeting boron agent. The boron concentration of phenylboronic acid was found to be 74.47 ± 12.17 ng/106 B16F10 cells and 45.77 ± 5.64 ng/106 cells in the nuclei. Molecular docking experiments were conducted to investigate the binding of phenylboronic acid to importin proteins involved in nuclear transport. The potential of phenylboronic acid to serve as a desirable nucleus-delivery boron agent for neutron capture therapy in melanoma warrants further exploration.
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Boronic Acids / Neutron Capture Therapy / Melanoma Limits: Humans Language: En Journal: Med Oncol Journal subject: NEOPLASIAS Year: 2024 Document type: Article Affiliation country: China
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Boronic Acids / Neutron Capture Therapy / Melanoma Limits: Humans Language: En Journal: Med Oncol Journal subject: NEOPLASIAS Year: 2024 Document type: Article Affiliation country: China